Three new dibenzocyclooctadiene lignans, marlignans M-O (1-3), together two known ones, were isolated from the leaves and stems of Schisandra wilsoniana. The structures of 1-3 were elucidated by spectroscopic methods, including extensive 1D-and 2D-NMR techniques. Compound 2 showed anti-HIV-1 activity with an EC 50 value of 5.82 μg/mL and a therapeutic index (TI) of more than 12.8. Compound 3 showed obvious bioactivity in inhibiting Epstein-Barr virus early antigen (EBV-EA) activation.
Compound 1, obtained as white amorphous powder, was assigned the molecular formula C 28 H 34 O 10 by HRESIMS {m/z 567.2201 [M + Na] + (calcd 567.2206)}. The 1 H and 13 C NMR spectra of 1 indicated the presence of 12 aromatic carbons, two aromatic protons, one methylenedioxy group, and four methoxyl groups, suggesting the presence of a biphenyl moiety [22] . HMBC correlations of H-11 (δ H 6.81, s) with C-9 (δ C 36.7, t), C-10 (δ C 138.2, s), and C-15 (δ C 122.6, s), and of H-4 (δ H 7.26, s) with C-5 (δ C 133.0, s), C-6 (δ C 87.3, s), and C-16 (δ C 123.6, s), together with 1 H-1 H COSY correlations of H-9/H-8/H-17 ( Figure 2 ) and UV R 1 =-OH R 2 =-OMe R 3 =H R 1 =-OH R 2 =-OH R 3 =H R 1 =-OH R 2 =-OH R 3 =-OH R 1 =-OH R 2 =-OH R 3 =H R 1 =-OH R 2 =-OH R 3 =H absorption bands at 215, 254, and 290 nm, implied that 1 was a dibenzocyclooctadiene lignan [6] . The 1 H and 13 C NMR spectra of compound 1 were similar to those of gomisin D [6] . In addition to the dibenzocyclooctadiene structure, the molecule still contained a structural unit consisting of a methoxy group and a six carbon chain [δ C 177. 5 13 , m) to C-14 (δ C 142.6, s) and H-6 (δ H 6.46, s) to C-1 (δ C 177.5, s) indicated that the above unit was connected to the dibenzocyclooctadiene skeleton, as shown in Figure 1 . The planar structure of 1 was initially deduced by comparison of the 1D NMR spectrum of 1 with that of gomisin D (4), the structure of which was determined by X-ray crystallographic analysis of its 4,11-dibromo derivative [6] . The only difference between 1 and 4 was that a hydroxyl group in 4 was substituted by a methoxy group in 1, which was supported by the appearance of a methoxy group signal in 1. The HMBC correlations of -OMe (δ H 3.08, s) with C-2 (δ C 80.3, s) indicated this methoxy group was attached to C-2. Thus, the planar structure of 1 was established.
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Since the CD spectra of dibenzocyclooctadiene lignans are dominated by the axial chirality of the biphenyl chromophore, the absolute configuration of the biphenyl axis of compound 1 could be determined from its CD curve, which showed a negative Cotton effect around 252 nm and a positive one around 210 nm. This suggested that 1 possessed an S-biphenyl configuration [21] . With the axial chirality defined, a ROESY experiment was used to establish the relative configuration of the remaining stereocenters. The ROESY correlations ( Figure 3) Since some of the dibenzocyclooctadiene lignans from Schisandra species exhibited modest or strong anti-HIV activities, compounds 1-3 were tested for their potencies in preventing the cytopathic effects of HIV-1 in C8166 and cytotoxicity measured in parallel with the determination of antiviral activity, using AZT as a positive control (EC 50 = 0.0045 mg/mL and CC 50 > 200 mg/mL) [24] . Compounds 1-3 showed weak anti-HIV-1 activities with EC 50 values of 16.8, 5.82 and 18.5 mg/mL, respectively, and all exerted minimal cytotoxicity against C8166 cells (CC 50 > 200 mg /mL). The therapeutic index (TI) values (CC 50 /EC 50 ) of 1-3 were more than 8.2, 12.8, and 6.3, respectively.
Some dibenzocyclooctadiene lignans from Schisandra species exhibited antitumor activities, The primary screening also used a short-term in vitro assay on EBV-EA activation. compounds showed inhibitory effects on EBV-EA activation without cytotoxicity to Raji cells. As shown in Table 3 , compound 3 showed potent inhibitory effects. Because inhibitory effects on EBV-EA activation correlate well with antitumor-promoting activity in vivo, these data suggest that 3 may be an antitumor promoter.
Experimental

General experimental procedures:
Optical rotations were measured with a Horiba SEPA-300 polarimeter. UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer. A Tenor 27 spectrophotometer was used for scanning IR spectroscopy with KBr pellets. CD spectra were measured on a JASCO J-810 spectropolarimeter. 1D and 2D NMR spectra were recorded on DRX-500 spectrometers with TMS as internal standard. Unless otherwise specified, chemical shifts (δ) were expressed in ppm with reference to the solvent signals. HRESIMS and FABMS were performed on an API QSTAR time-of-flight spectrometer and a VG Autospec-3000 spectrometer, respectively. Semipreparative HPLC was performed on an Agilent 1100 liquid chromatograph with a Zorbax SB-C 18 
Anti-HIV-1 assay:
The cytotoxicity assay against C8166 cells (CC 50 ) was assessed using the MTT method, and anti-HIV-1 activity by the inhibition assay for cytopathogenic effects of HIV-1 (EC 50 ) [23] .
In vitro EBV-EA activation experiments:
The inhibition of EBV-EA activation was assayed using Raji cells (virus nonproducer type), EBV genome-carrying human lymphoblastoid cells, which were cultivated in 10% fetal bovine serum (FBS) RPMI 1640 medium. The indicator cells (Raji, 1 × 10 6 /mL) were incubated at 37°C for 48 h in 1 mL of medium containing n-butyric acid (4 mM, inducer), TPA (32 pM), and various amounts of the test compounds dissolved in 5.0 mL of DMSO. Smears were made from the cell suspension. The EBVEA inducing cells were stained with high-titer EBV-EA positive serum from NPC patients and detected by an indirect immunofluorescence technique. In each assay, 500 cells were counted, and the number of stained cells (positive cells) was recorded. Triplicate assays were performed for each data point. The EBV-EA inhibitory activity of the test compound was expressed by comparison with that of the positive control experiment (100%), which was carried out with n-butyric acid (4.0 mM) plus TPA (32 pM). In the experiments, the EBV-EA induction was ordinarily around 35%, and this value was taken as the positive control (100%). 4.0 mM n-butyric acid alone induced 0.1% EA-positive cells. The viability of treated Raji cells was assayed by the trypanblue staining method [25, 26] . 
